Supplement use is common among people undergoing cancer treatment, and it is also the situation where interactions carry the highest stakes.
What are the concerns?
Three main ones. Supplements can alter chemotherapy drug levels through liver enzymes, they may interfere with the mechanisms treatment uses, and some affect blood counts or bleeding.
Reduced drug levels can mean undertreatment, while increased levels can mean greater toxicity.
Which supplements affect drug levels?
- St Johns wort, which reduces levels of several cancer drugs including imatinib and irinotecan
- Grapefruit and related products, which inhibit the same enzymes in the opposite direction
- Various herbal products affecting CYP enzymes with less well characterised effects
- High dose vitamins and botanicals with limited interaction data
What is the antioxidant concern?
Some chemotherapy and radiotherapy work partly by generating oxidative damage in tumour cells.
The theoretical concern is that high dose antioxidants could reduce that effect.
Evidence is genuinely mixed, with some research suggesting reduced side effects and other work raising concerns about efficacy.
This is an unresolved question and precisely why the decision belongs with the treating team rather than being made independently.
Why is it so often not discussed?
Surveys have found that a substantial proportion of people using supplements during cancer treatment do not tell their team.
Reasons include assuming natural products are irrelevant, expecting disapproval, and not being asked directly.
Oncology teams generally want to know rather than to judge, since the information affects treatment decisions.
Are any supplements used deliberately?
Yes. Teams may recommend specific supplements for identified deficiencies, for bone health during hormone treatments, or for particular side effects.
Those are prescribed decisions rather than self selected ones.
What about after treatment?
Interactions can persist with ongoing treatments including hormone therapies, which continue for years in some cancers.
Tamoxifen in particular is affected by supplements influencing the enzymes that activate it.
What should you do?
Tell your oncology team everything you take, including vitamins and herbal products, and ask before starting anything new.
This article is general information and not medical advice.
What about immunotherapy?
Immune checkpoint inhibitors work by activating immune responses, and whether supplements affecting immune function interact is not well characterised.
This is another reason to raise anything you take with the treating team rather than assuming irrelevance.
What about probiotics?
People who are severely immunocompromised, including during some chemotherapy, are advised against live probiotic products because of infection risk.
This is a specific and well recognised caution.
What is the summary?
Genuine potential to affect drug levels and possibly treatment mechanisms, in a context where the stakes are highest.
Tell your oncology team everything you take, including vitamins.
What should you ask?
Whether anything you take should stop, whether anything should be avoided during treatment, and whether anything is recommended.
Teams generally have clear positions on these questions and are rarely asked.
What about during radiotherapy?
Similar antioxidant considerations apply, since radiotherapy also works partly through oxidative damage.
The treating team can advise on what is appropriate during and after treatment.
What about supportive supplements?
Teams may recommend specific products for identified deficiencies, bone protection during hormone therapy, or particular side effects.
Those recommendations account for the treatment being given, which self selected products cannot.
What about complementary therapies generally?
Many people use them alongside conventional treatment, and teams are generally more concerned with knowing than with objecting.
An open conversation produces better decisions than an undisclosed one.
What about after treatment ends?
Hormone therapies continue for years in some cancers, and interactions with them persist throughout.
Checking again when treatment changes is worthwhile rather than assuming the earlier answer still applies.
Specialist cancer nurses are often the easiest people to ask, since they generally have more time available than a brief clinic appointment allows.
Written information from the treating hospital frequently covers supplements, and reading it is worthwhile even when nothing is asked about them directly.
Asking is straightforward and the answer is frequently reassuring.